%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/2162402X.2020.1738812
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial
Julie Charles
Laurence Chaperot
Dalil Hannani
Juliana Bruder Costa
Isabelle Templier
Sabiha Trabelsi
Hugo Gil
Anaick Moisan
Virginie Persoons
Harald Hegelhofer
Edith Schir
Jean-Louis Quesada
Christophe Mendoza
Caroline Aspord
Olivier Manches
Pierre G. Coulie
Amir Khammari
Brigitte Dreno
Marie-Thérèse Leccia
Joel Plumas
Taylor & Francis
OncoImmunology, 2020. doi:10.1080/2162402X.2020.1738812
Plasmacytoid dendritic cells
vaccination
peptide-vaccines
melanoma
clinical study
immunotherapy
immune checkpoint blockers
en
Journal
OncoImmunology
© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.
2162-402X
9
1
10.1080/2162402X.2020.1738812
https://doi.org/10.1080/2162402X.2020.1738812
VoR
application/pdfdoi:10.1080/2162402X.2020.173881210.1080/2162402X.2020.1738812https://doi.org/10.1080/2162402X.2020.17388122020-04-12truewww.tandfonline.com10.1080/2162402X.2020.1738812www.tandfonline.comtrue2020-04-1210.1080/2162402X.2020.1738812
endstream
endobj
4 0 obj
<>stream
xZɎ&
SDZ 9 çv%")=d`ѨK"~y
᭥|^K./5ntͣ/~C.ŵʒK)}[>.}=.h
Wx;a
Txe\DK3l~Igѿ4˧?dPK^T;UAe\1dۊ ,oRm<!3UVAЖMe.}e>1}K+iY3R!pPӷ1u`P;ƫKHPz"O?x_䝯.{\Zy}9?fƿ=V;h耄W<5,(Aa4km;dCkcQEE tsN܌|X
vp